Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4P-004 in knee synovitis and osteoarthritis
2024-518916-38-00Phase 2Completed
- Sponsor
- 4Moving Biotech
- Start
- Sep 2025
- Modality
- Peptides
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial in osteoarthritis (OA) and synovitis comparing 4P-004 intra-articular with Placebo (2 arms). Primary endpoint: Change from baseline at Week 4 in weekly average target knee daily pain intensity using the WOMAC Pain subscore. Started Sep 2025; status: completed.
02
Drugs
03
Conditions
osteoarthritis (OA)synovitis
Beyond the preview
Go deeper on 2024-518916-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518916-38-00.